316 related articles for article (PubMed ID: 23872029)
1. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.
Jeong KC; Kim KT; Seo HH; Shin SP; Ahn KO; Ji MJ; Park WS; Kim IH; Lee SJ; Seo HK
J Urol; 2014 Feb; 191(2):510-8. PubMed ID: 23872029
[TBL] [Abstract][Full Text] [Related]
2. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.
Seo HK; Ahn KO; Jung NR; Shin JS; Park WS; Lee KH; Lee SJ; Jeong KC
Oncotarget; 2014 Jan; 5(2):326-37. PubMed ID: 24504118
[TBL] [Abstract][Full Text] [Related]
4. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
5. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
Xiao Z; Mak A; Koch K; Moore RB
BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
[TBL] [Abstract][Full Text] [Related]
7. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
[TBL] [Abstract][Full Text] [Related]
9. Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft models.
Zhang B; Dong S; Cen X; Wang X; Liu X; Zhang H; Zhao X; Wu Y
Anticancer Drugs; 2012 Jul; 23(6):590-6. PubMed ID: 22241170
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
11. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
12. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
13. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
Kang MR; Yang G; Place RF; Charisse K; Epstein-Barash H; Manoharan M; Li LC
Cancer Res; 2012 Oct; 72(19):5069-79. PubMed ID: 22869584
[TBL] [Abstract][Full Text] [Related]
14. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
Liu H; Schwartz MJ; Hwang DH; Scherr DS
BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
16. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
17. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.
Nogawa M; Yuasa T; Kimura S; Tanaka M; Kuroda J; Sato K; Yokota A; Segawa H; Toda Y; Kageyama S; Yoshiki T; Okada Y; Maekawa T
J Clin Invest; 2005 Apr; 115(4):978-85. PubMed ID: 15761500
[TBL] [Abstract][Full Text] [Related]
18. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
Zhang PH; Zou L; Tu ZG
J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
[TBL] [Abstract][Full Text] [Related]
19. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
